# Franklin Covey share price today (Franklin Covey Co., FC)

> Franklin Covey Co.'s share price, valuation and earnings point in different directions. The next one or two quarters should make it clearer. FC · Consumer Staples · Education & Training Services · data as of 3 November 2026. Page: https://www.sectoralpha.in/us/stocks/fc

Sector Alpha also publishes a daily newsletter that explains one Indian stock at a time: https://newsletter.sectoralpha.in/?utm_source=sectoralpha&utm_medium=ai_text&utm_campaign=llms

## Key numbers

- Business trend: Mixed, from the last 12 quarters
- Price: $17.17 (+1.1% in a year)
- P/E: 93.3× (higher than 61% of the last 1 year)
- Revenue (May 2026): $67.8 M (+1.0% on a year ago)
- Profit (May 2026): $3.1 M
- Operating margin: 7.4% (+3.0 points on a year ago)
- ROE: 5%, FY25
- ROIC: 15.6%, against a 8.5% cost of capital: +7.1 points

The main question: the share price moved +1.1% in a year while yearly earnings per share moved −86.4%. The difference came from the market paying a higher multiple. ## What is the Franklin Covey share price today? Franklin Covey Co.'s share price was $17.17 at the close on 3 November 2026. That is 12.4% below its average price over the last 200 trading days. In the last 52 weeks it traded between $12 and $25, and at that close it sat 42% of the way up from that low. Over the past 13 weeks it has done worse than the S&P 500, and it has been behind for 19 weeks running. Over the last 1 year the share price moved −14% while the S&P 500 moved +21%, so it is behind the index over that whole period. It was last ahead over 13 weeks in the week of 26 June 2026. The chart above shows the 13-week comparison for every week. This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row. ## What dividend does Franklin Covey pay? Franklin Covey Co. pays no dividend. In the last 12 reported quarters it declared no dividend per share, so there is no payout history to chart and no yield to show. Companies like this usually keep their earnings in the business, so the cash-flow sections show where that cash goes. ## Which stock lists is Franklin Covey on? Franklin Covey is not in the Nasdaq 100, the S&P 500 or the Dow Jones 30, and is not on the US tech stocks list. ## Is Franklin Covey profitable? Franklin Covey Co. earned $3.1 M of net profit in the May 2026 quarter. Full-year FY25 profit was $3.1 M. Over 4 years profit has grown −31.1% a year on average. That is 4.5% of the quarter's revenue. The same quarter a year earlier lost $1.4 M. 4 of the last 12 reported quarters were loss-making. For the full year, FY25 profit was $3.1 M (−86.9% on the year before). ## How much revenue does Franklin Covey make, and is it growing? Franklin Covey Co. reported $67.8 M of revenue in the May 2026 quarter, +1.0% on the same quarter a year earlier. That is the 2nd quarter in a row with growth on the year before. Over 4 years it has grown 4.5% a year on average. The last full year, FY25, came in at $267 M. The last four reported quarters add to $263 M. FY25 revenue was $267 M, −7.0% on the year before. Recent pace: the last four quarters grew −5.4% on average, against 4.5% a year over the longer run, so this year is growing slower than its own long-run rate. Is growth speeding up? Revenue over the last 12 months grew −6.1%, against −3.3% a year over the last 8 quarters (stabilising); profit over the last 12 months grew −79.5%, against −65.4% a year (rolling over). ## How much of every $100 of sales does Franklin Covey keep? Franklin Covey Co.'s operating margin was 7.4% in the May 2026 quarter, 3.0 percentage points higher than the same quarter a year ago. Across 5 years it has been between 3.8% and 12.9%. The latest quarter is within that range. Why the margin moved: operating margin changed +3.0 percentage points on the year while gross margin changed −2.6 points. So the gain came mostly from the gross margin, which means input costs and prices charged. ## Is Franklin Covey's profit turning into cash? Over the last 3 years, 282% of Franklin Covey Co.'s reported profit came in as cash from its operations, so the profit is backed by cash. In FY25 it brought in $29.0 M of operating cash against $3.1 M of profit. After $8.3 M of spending on assets, $20.7 M was left over as free cash. Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year. Why: the cash figure is clear, but the day counts behind it are not in our data, so we show it without guessing the reason. What to look at next: the main use of cash is spending on assets. The next section checks what that spending is building. ## Where does Franklin Covey's cash go? Franklin Covey Co. does not report the customer, stock and supplier day counts a cash cycle needs, so this section looks at its spending on assets instead. It spent $16.5 M on assets over the last 3 years. Averaged over those years that is 2.1% of FY25 revenue a year. Nothing is estimated in place of the missing day counts, so no cash-cycle chart is drawn. Spending on assets: $16.5 M over the last 3 years. In short: the cash is going into new capacity, not getting stuck in the daily cycle. The question is whether the new capacity earns. ## What is Franklin Covey's P/E ratio, and how does it compare with its own history? Franklin Covey Co.'s P/E is 93.3×, in the middle of its own history: higher than 61% of past readings. Its usual P/E (the middle reading) is 79.5×, over 1 year of weekly prices. This compares the share price with the company’s own past. It does not say what the business is worth. Why the multiple is where it is: over the past year earnings per share moved −86.4% while the price moved +1.1%. The price did better than earnings, which pushed the multiple up within its own range. In short: the multiple is about average against its own past, so the earnings trend underneath matters more than the multiple. ## Is the Franklin Covey business getting better or worse? Franklin Covey Co.'s business is giving mixed signals. Revenue, profit and EPS growth are shrinking while ROCE is still rising at 18.6%, so growth and returns point different ways. This is based on 12 quarters of 4 measures. Why it matters: when the lines disagree, each line above matters more than any single label. ## How much does Franklin Covey earn on its capital? Franklin Covey Co. earned a ROE of 5% in FY25. Its return on capital used (ROIC) is 7.1 percentage points above its cost of capital, so growth here adds value, not just size. It comes from a 1.1% net margin and 1.10× asset turnover (sales divided by assets). Why the return is what it is (FY25): a 1.1% net margin × 1.10× asset turnover × 3.63× leverage (assets divided by equity) ≈ 4.4% on equity. The margin does its share; borrowing is a big part of it. The key test, return on capital used minus the cost of capital: 15.6% − 8.5% = +7.1 percentage points. The 8.5% is an estimate of this company's own cost of capital. Read the sign and size of the gap, not the decimals. A gap this wide means each dollar put back into the business creates more than a dollar of value. ## Does Franklin Covey have too much debt? Franklin Covey Co. has total debt of $835 K against shareholder equity of $38.0 M as of Feb 2026, so its debt is 0.02× its equity, which is very little. Year by year, that ratio went from 0.41 in FY21 to 0.12 in FY25. So the returns on this page come from the business, not from borrowed money. ## What is the Franklin Covey shareholding pattern? 8.8% of Franklin Covey Co.'s tradable shares are in short positions, which are bets that the price will fall, so some traders are betting against it. At normal trading volumes, closing those positions would take about 15.5 days. US companies do not publish a quarter-by-quarter list of owners, so this page uses short interest instead. It is a single reading at one point in time; we do not have its history. Why it is at this level: the figure does not say who holds the short positions or why, so we show the level without guessing the story. ## How far is Franklin Covey from balance-sheet trouble? For Franklin Covey Co., the Z-score is 3.01. A Z-score above about 3 is safe and below about 1.8 signals danger, so this is well clear of danger. It estimates how far the balance sheet is from trouble; it is not a forecast of failure. Why it matters: a Z-score of 3.01 is well clear of the danger zone, so the balance sheet is not the risk here. ## How does Franklin Covey rank in its industry? 41.2 out of 100, rank 14 of 20 in Education & Training Services, with 74% of the evidence available. Franklin Covey Co. scores 41.2 out of 100 against the 20 companies it is compared with in Education & Training Services, ranking 14. The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. The four parts add up to the total exactly: 13.7 + 15.3 + 6.8 + 5.4 = 41.2. This is the same number shown on the industry page; it is worked out once for the whole group and read here. What would change it: The score would fall if profit growth turns negative or margins stop improving while the share price lags its sector. ## Which companies is Franklin Covey compared with? Franklin Covey ranks 14 of 20 Education & Training Services companies on the 4-Factor Sector Score, with 41.2 out of 100. 1. [Laureate Education, Inc.](https://www.sectoralpha.in/us/stocks/laur) LAUR · quiet · Most evidence points up · 81% evidence 65.5 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 17.9/35 · Revenue 17.9% · Profit 25.4% · Operating margin change -0.6 points · 83% evidence Capital efficiency 18.1/25 · ROCE 23.4% · Operating margin 36.3% · 76% evidence Valuation 14.2/20 · P/E 15.8× · PEG 0.5 · 65% evidence Relative strength 15.3/20 · Lead over its industry 5.1% · Lead over S&P 500 -2.9% · 1 year 16.8% · 100% evidence · 2 of 12 weeks ahead Exact sum: 17.9 + 18.1 + 14.2 + 15.3 = 65.5 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 2. [Covista Inc.](https://www.sectoralpha.in/us/stocks/cvsa) CVSA · quiet · Evidence leans up · 81% evidence 62.3 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 18.4/35 · Revenue 9.2% · Profit 6.3% · Operating margin change 2.4 points · 83% evidence Capital efficiency 16.1/25 · ROCE 16.1% · Operating margin 19.3% · 76% evidence Valuation 9.7/20 · P/E 16.9× · PEG 1.28 · 65% evidence Relative strength 18.1/20 · Lead over its industry 9.1% · Lead over S&P 500 0.7% · 1 year 29.1% · 100% evidence · 2 of 12 weeks ahead Exact sum: 18.4 + 16.1 + 9.7 + 18.1 = 62.3 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 3. [Stride, Inc.](https://www.sectoralpha.in/us/stocks/lrn) LRN · basing · Evidence leans up · 85% evidence 61.9 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 18.2/35 · Revenue 2.5% · Profit 6% · Operating margin change 2.1 points · 95% evidence Capital efficiency 18.4/25 · ROCE 25.4% · Operating margin 13.6% · 76% evidence Valuation 13.4/20 · P/E 9.6× · PEG 0.81 · 65% evidence Relative strength 11.9/20 · Lead over its industry -5.4% · Lead over S&P 500 -12.8% · 1 year 4.2% · 100% evidence · 0 of 12 weeks ahead Exact sum: 18.2 + 18.4 + 13.4 + 11.9 = 61.9 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 4. [Perdoceo Education Corporation](https://www.sectoralpha.in/us/stocks/prdo) PRDO · quiet · Evidence leans up · 81% evidence 61.4 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 19.5/35 · Revenue 11.7% · Profit 14.9% · Operating margin change 1.2 points · 83% evidence Capital efficiency 18.2/25 · ROCE 18.1% · Operating margin 25.7% · 76% evidence Valuation 13.8/20 · P/E 11.3× · PEG 0.58 · 65% evidence Relative strength 9.9/20 · Lead over its industry -6.2% · Lead over S&P 500 -13.5% · 1 year -1.6% · 100% evidence · 1 of 12 weeks ahead Exact sum: 19.5 + 18.2 + 13.8 + 9.9 = 61.4 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 5. [New Oriental Education & Technology Group Inc.](https://www.sectoralpha.in/us/stocks/edu) EDU · quiet · Evidence leans up · 81% evidence 60.1 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 22.9/35 · Revenue 15.5% · Profit 28% · Operating margin change 1.4 points · 83% evidence Capital efficiency 11.0/25 · ROCE 13.1% · Operating margin 5.6% · 76% evidence Valuation 14.7/20 · P/E 15.3× · PEG 0.47 · 65% evidence Relative strength 11.5/20 · Lead over its industry -4.4% · Lead over S&P 500 -11.5% · 1 year -7.6% · 100% evidence · 10 of 12 weeks ahead Exact sum: 22.9 + 11 + 14.7 + 11.5 = 60.1 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 6. [Grand Canyon Education, Inc.](https://www.sectoralpha.in/us/stocks/lope) LOPE · quiet · Evidence leans up · 81% evidence 60.0 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 18.3/35 · Revenue 7% · Profit -5.5% · Operating margin change 1.1 points · 83% evidence Capital efficiency 21.0/25 · ROCE 39.6% · Operating margin 22% · 76% evidence Valuation 7.0/20 · P/E 16.7× · PEG 1.9 · 65% evidence Relative strength 13.7/20 · Lead over its industry -3.6% · Lead over S&P 500 -10.8% · 1 year -10.5% · 100% evidence · 2 of 12 weeks ahead Exact sum: 18.3 + 21 + 7 + 13.7 = 60 · What this means: A strong business with a high valuation: it would need rising earnings, or a lower multiple, to score better on value. 7. [Graham Holdings Company](https://www.sectoralpha.in/us/stocks/ghc) GHC · turning · Evidence leans up · 81% evidence 57.2 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 12.7/35 · Revenue 4.8% · Profit -20.6% · Operating margin change 10.9 points · 83% evidence Capital efficiency 10.3/25 · ROCE 8% · Operating margin 19.7% · 76% evidence Valuation 16.0/20 · P/E 9.1× · PEG 0.29 · 65% evidence Relative strength 18.2/20 · Lead over its industry 9% · Lead over S&P 500 0.8% · 1 year 14% · 100% evidence · 0 of 12 weeks ahead Exact sum: 12.7 + 10.3 + 16 + 18.2 = 57.2 · What this means: Relative strength against the index is 0.8%, and revenue and profit growth are weak. 8. [Strategic Education, Inc.](https://www.sectoralpha.in/us/stocks/stra) STRA · quiet · Evidence leans up · 81% evidence 54.8 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 17.6/35 · Revenue 3.5% · Profit 17.4% · Operating margin change 0.6 points · 83% evidence Capital efficiency 12.3/25 · ROCE 11.2% · Operating margin 15.7% · 76% evidence Valuation 14.4/20 · P/E 12.7× · PEG 0.52 · 65% evidence Relative strength 10.5/20 · Lead over its industry -5% · Lead over S&P 500 -12.1% · 1 year -2.6% · 100% evidence · 2 of 12 weeks ahead Exact sum: 17.6 + 12.3 + 14.4 + 10.5 = 54.8 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 9. [TAL Education Group](https://www.sectoralpha.in/us/stocks/tal) TAL · quiet · Evidence leans up · 71% evidence 54.2 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 29.2/35 · Revenue 32.4% · Profit 100% · Operating margin change 15.6 points · 83% evidence Capital efficiency 9.2/25 · ROCE 8.7% · Operating margin 18.1% · 76% evidence Valuation 11.1/20 · P/E 6.5× · PEG n/a · 15% evidence Relative strength 4.7/20 · Lead over its industry -7.5% · Lead over S&P 500 -14.3% · 1 year -15% · 100% evidence · 9 of 12 weeks ahead Exact sum: 29.2 + 9.2 + 11.1 + 4.7 = 54.2 · What this means: Earnings are strong; relative strength in its sector is -7.5% and the one-year return is -15%. 10. Legacy Education Inc. LGCY · quiet · Evidence leans up · 81% evidence 52.0 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 22.3/35 · Revenue 21.5% · Profit 28.6% · Operating margin change 1.9 points · 83% evidence Capital efficiency 15.1/25 · ROCE 17.8% · Operating margin 13% · 76% evidence Valuation 9.4/20 · P/E 16.3× · PEG 1.4 · 65% evidence Relative strength 5.2/20 · Lead over its industry -12.9% · Lead over S&P 500 -19.7% · 1 year 13.4% · 100% evidence · 0 of 12 weeks ahead Exact sum: 22.3 + 15.1 + 9.4 + 5.2 = 52 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 11. [American Public Education, Inc.](https://www.sectoralpha.in/us/stocks/apei) APEI · quiet · Evidence leans down · 64% evidence 43.5 out of 100 Growth Capital Valuation Relative
12. [Phoenix Education Partners, Inc.](https://www.sectoralpha.in/us/stocks/pxed) PXED · basing · Evidence leans down · 65% evidence 43.3 out of 100 Growth Capital Valuation Relative
13. [McGraw Hill, Inc.](https://www.sectoralpha.in/us/stocks/mh) MH · breaking out · Evidence leans down · 64% evidence 43.0 out of 100 Growth Capital Valuation Relative
14. Franklin Covey Co. this page FC · quiet · Evidence leans down · 74% evidence 41.2 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 13.7/35 · Revenue -6.1% · Profit -81.8% · Operating margin change 3 points · 62% evidence Capital efficiency 15.3/25 · ROCE 23.1% · Operating margin 7.4% · 76% evidence Valuation 6.8/20 · P/E 122.3× · PEG 1.74 · 65% evidence Relative strength 5.4/20 · Lead over its industry -6.6% · Lead over S&P 500 -13.9% · 1 year 15.3% · 100% evidence · 0 of 12 weeks ahead Exact sum: 13.7 + 15.3 + 6.8 + 5.4 = 41.2 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 15. [Lincoln Educational Services Corporation](https://www.sectoralpha.in/us/stocks/linc) LINC · quiet · Evidence leans down · 81% evidence 39.8 out of 100 Growth Capital Valuation Relative
16. [Coursera, Inc.](https://www.sectoralpha.in/us/stocks/cour) COUR · quiet · Evidence leans down · 61% evidence 38.9 out of 100 Growth Capital Valuation Relative
17. [KinderCare Learning Companies, Inc.](https://www.sectoralpha.in/us/stocks/klc) KLC · basing · Too little evidence to rank firmly · 58% evidence 30.6 out of 100 Growth Capital Valuation Relative
18. [Universal Technical Institute, Inc.](https://www.sectoralpha.in/us/stocks/uti) UTI · basing · Most evidence points down · 81% evidence 30.4 out of 100 Growth Capital Valuation Relative
19. Neucleus Group Limited NEUC · Too little evidence to rank firmly · 11% evidence 57.2 out of 100 Growth Capital Valuation Relative
20. Chegg, Inc. CHGG · Too little evidence to rank firmly · 44% evidence 43.2 out of 100 Growth Capital Valuation Relative

Missing figures are not scored as bad. They lower the confidence and pull the final score toward the middle. Relative strength counts only when the company has a reading for this week; with no reading, that factor is left out and its 20 points are shared across the other three in proportion. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led S&P 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step path the industry is placed on (basing, turning, breaking out, leader, fading, asleep), read from how many weeks running it has led S&P 500 and whether that lead is growing or shrinking. It describes where the share price stands, not the direction of earnings, and it is not a recommendation; it is left blank for a company whose weekly history is too short or too stale to read. The figures in this ranking come from the industry comparison: results through the Sep 2026 quarter, and the P/E at that quarter's end. The sections above use the latest weekly price, so a P/E or return there can differ a little from the one here. The stage words in this ranking (such as losing its lead or breaking out) describe the lead over the index, not the price phase in the price section. Related companies: [Education & Training Services](https://www.sectoralpha.in/us/sectors/education-training-services), all 20 compared on one page. ## Which companies are close to Franklin Covey in size? Franklin Covey is the 20th largest of 20 Education & Training Services companies on Sector Alpha by market value (scores of 3 November 2026). Just above it: Afya, Phoenix Education Partners, Inc., American Public Education, Inc., Lincoln Educational Services Corporation, Gaotu Techedu Inc. and KinderCare Learning Companies, Inc. It is the smallest. ### Education & Training Services companies close in size

1. [Afya Limited](https://www.sectoralpha.in/us/stocks/afya) $933 million
2. [Phoenix Education Partners, Inc.](https://www.sectoralpha.in/us/stocks/pxed) $843 million
3. [American Public Education, Inc.](https://www.sectoralpha.in/us/stocks/apei) $775 million
4. [Lincoln Educational Services Corporation](https://www.sectoralpha.in/us/stocks/linc) $650 million
5. [Gaotu Techedu Inc.](https://www.sectoralpha.in/us/stocks/gotu) $536 million
6. [KinderCare Learning Companies, Inc.](https://www.sectoralpha.in/us/stocks/klc) $244 million
7. Franklin Covey Co. $194 million

[All 20 Education & Training Services companies, largest first](https://www.sectoralpha.in/us/sectors/education-training-services#all-companies)

### Companies close in size in other industries

1. [Smart Sand, Inc.](https://www.sectoralpha.in/us/stocks/snd) $205 million · Oil & Gas Equipment & Services
2. [Artiva Biotherapeutics, Inc.](https://www.sectoralpha.in/us/stocks/artv) $205 million · Biotechnology
3. Franklin Covey Co. $204 million
4. [Eagle Point Income Company Inc.](https://www.sectoralpha.in/us/stocks/eic) $203 million · Asset Management
5. [Perfect Corp.](https://www.sectoralpha.in/us/stocks/perf) $203 million · Software - Application

## What else do people ask about Franklin Covey? ### What were Franklin Covey's latest quarterly results? Franklin Covey Co. reported revenue of $67.8 M and net profit of $3.1 M for the May 2026 quarter. Earnings per share were $0.27. The operating margin was 7.4%, 3.0 percentage points higher than a year earlier (as of 3 November 2026). ### What is Franklin Covey's market cap? Franklin Covey Co.'s market capitalisation is $194 M at a stock price of $17.17. Market cap is the share price times the number of shares, so it changes whenever the price moves (as of 3 November 2026). ### How is Franklin Covey performing? Franklin Covey Co.'s latest readings are below. Over the past 13 weeks it has done worse than the S&P 500, for 19 weeks running. This describes what the data did, not a rating (as of 3 November 2026). ### Will Franklin Covey's stock price go up? This page does not forecast Franklin Covey Co.'s stock price. What it shows instead: the stock price is $17.17. Its P/E of 93.3× is higher than 61% of its own last 1 years. Nobody can reliably say which way a price will move, and this site does not try (as of 3 November 2026). ### Where is Franklin Covey in its business cycle? Franklin Covey Co.'s FY25 operating margin was 4.7%, against a 5-year range of 3.8% to 12.9%: the low end of its own range, which is often where recoveries start. The latest quarter was 7.4%. Comparing margins with a company's own long history is a good way to see where it is in its cycle (as of 3 November 2026). ### What could break the Franklin Covey story? The main question: the share price moved +1.1% in a year while yearly earnings per share moved −86.4%. The difference came from the market paying a higher multiple. On price, this page treats a rise as over when the share price closes below its 200-day average on two Fridays in a row (as of 3 November 2026). ### Is Franklin Covey a stock worth studying right now? What the numbers show: Franklin Covey Co.'s share price, valuation and earnings point in different directions. The next one or two quarters should make it clearer. The main open question: whether earnings grow into a price that has already moved. Every number on this page is worked out by code from the published figures, with no forecasts and no price opinions (as of 3 November 2026). This is research, not advice. We’re not SEBI-registered.